Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
18.37
27.95
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jiang Zhong Pharmaceutical Co Ltd
Accrued Liabilities
Jiang Zhong Pharmaceutical Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
|
Accrued Liabilities
ÂĄ175.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
32%
|
CAGR 10-Years
9%
|
||
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accrued Liabilities
ÂĄ2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accrued Liabilities
ÂĄ620.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
39%
|
CAGR 10-Years
35%
|
||
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accrued Liabilities
ÂĄ128.5m
|
CAGR 3-Years
456%
|
CAGR 5-Years
130%
|
CAGR 10-Years
63%
|
||
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accrued Liabilities
ÂĄ1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
46%
|
CAGR 10-Years
59%
|
||
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Accrued Liabilities
ÂĄ146m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Jiang Zhong Pharmaceutical Co Ltd
Glance View
Jiangzhong Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Nanchang, Jiangxi and currently employs 4,153 full-time employees. The Company’s products include OTC medicines, healthcare products and functional food, as well as wine. Its OTC pharmaceuticals include indigestion tablets, lactobacillin tablets and sarcandra glabra tablets, among others. Its healthcare products and functional food include calcium tablets and ginseng products, among others. The firm mainly operates its businesses in domestic market.
See Also
What is Jiang Zhong Pharmaceutical Co Ltd's Accrued Liabilities?
Accrued Liabilities
175.6m
CNY
Based on the financial report for Sep 30, 2024, Jiang Zhong Pharmaceutical Co Ltd's Accrued Liabilities amounts to 175.6m CNY.
What is Jiang Zhong Pharmaceutical Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
9%
Over the last year, the Accrued Liabilities growth was 46%. The average annual Accrued Liabilities growth rates for Jiang Zhong Pharmaceutical Co Ltd have been 34% over the past three years , 32% over the past five years , and 9% over the past ten years .